MYRIAD GENETICS INC Management’s Discussion and Analysis of Financial Condition and Results of Operations (Dollars and shares in millions, except per share data) (form 10-Q)

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the unaudited Condensed Consolidated Financial Statements and the related notes thereto included in this Quarterly Report on Form 10-Q and the audited Consolidated Financial Statements and notes thereto and Management’s Discussion and Analysis of Financial Condition … Read more

Fulgent Genetics Announces Launch of PCR Based Test to Detect Monkeypox

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics”, “Fulgent”, or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health , today announced it has launched a test for monkeypox that leverages the US Centers for Disease Control and Prevention’s (CDC) orthopoxvirus test, which detects … Read more

Fulgent Genetics : Statement of Changes in Beneficial Ownership – Form 4

Ownership Submission FORM 4 Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. see Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, DC 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) … Read more

MYRIAD GENETICS INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)

ITEM 1.01 Entry into a Material Definitive Agreement. On July 26, 2022, Myriad Genetics, Inc. (the “Company” or “Myriad”) entered into Amendment No. 4 (“Amendment No. 4”) to its Credit Agreement, dated December 23, 2016 (as amended as of July 31, 2018, May 1, 2020and February 22, 2021), by and among Myriad, as borrower, the … Read more